Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

This study has been completed.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI) Identifier:
First received: July 21, 2008
Last updated: August 29, 2008
Last verified: July 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)